Antiviral activity of HIV‐1 integrase strand‐transfer inhibitors against mutants with integrase resistance‐associated mutations and their frequency in treatment‐naïve individuals-Reference-Cited by-同舟云学术

Antiviral activity of HIV‐1 integrase strand‐transfer inhibitors against mutants with integrase resistance‐associated mutations and their frequency in treatment‐naïve individuals

Published:2019-08-20 Issue:12 Volume:91 Page:2188-2194
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Margot Nicolas A.¹^ORCID,Ram Renee R.¹,White Kirsten L.¹,Abram Michael E.¹,Callebaut Christian¹

Affiliation:

1. Gilead Sciences, Inc.Clinical virology Foster City California

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.25564

Reference31 articles.

1. U.S. Department of Health & Human Services (DHHS).Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV‐What to Start: Initial Combination Regimens for the Antiretroviral‐naive Patient. Available at:https://aidsinfo.nih.gov/guidelines/html/1/adult‐and‐adolescent‐arv/11/what‐to‐start. Last updated: 17 October 2017.

2. Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV ‐positive persons version 9.0

3. Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial

4. Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

5. Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-1 Integrase T218I/S Polymorphisms Do Not Reduce HIV-1 Integrase Inhibitors’ Phenotypic Susceptibility;AIDS Research and Human Retroviruses;2024-08-20

2. Pretreatment integrase strand transfer inhibitor resistance in Tianjin, China;Chinese Medical Journal;2023-11-03

3. Biktarvy for the treatment of HIV infection: Progress and prospects;Biochemical Pharmacology;2023-11

4. Virological outcomes of various first-line ART regimens in patients harbouring HIV-1 E157Q integrase polymorphism: a multicentre retrospective study;Journal of Antimicrobial Chemotherapy;2023-10-19

5. Population dynamics of HIV drug resistance among pre-treatment and treatment-experienced persons with HIV during treatment scale-up in Uganda: a population-based longitudinal study;2023-10-15